ARROW Pharmaceuticals is offering all delegates to this week's APP2017 conference access to a new Dispensary Analysis Tool.
Developed in conjunction with consulting firm Sinapse, the tool reports on gross profit dollars to generate accurate financial forecasts of dispensary business.
Arrow executive chairman Dennis Bastas said analysing revenue alone was risky, given the "distortive nature of some high cost medicines and the continuing nature of price disclosure".
The tool will be presented by APP chairman and Sinapse consultant Kos Sclavos this Thu 09 Mar - see appconference.com.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Mar 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Mar 17